Clinical Trials Directory

Trials / Conditions / Lymphoma, B-Cell, Marginal Zone

Lymphoma, B-Cell, Marginal Zone

9 registered clinical trials studyying Lymphoma, B-Cell, Marginal Zone — 1 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies
NCT07476378
Cancer Institute and Hospital, Chinese Academy of Medical SciencesN/A
Active Not RecruitingOrelabrutinib Followed by Response-adapted Ultra-low Dose 4Gy Radiation as First-line Treatment of MALT Lympho
NCT06583837
Fudan UniversityPhase 2
Active Not RecruitingStudy of Oral LOXO-338 in Patients With Advanced Blood Cancers
NCT05024045
Eli Lilly and CompanyPhase 1
CompletedA Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia)
NCT04849416
Eli Lilly and CompanyPhase 2
CompletedVincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab-Phase I Trial in Indolent B-cell
NCT02257242
Brown UniversityPhase 1
UnknownAEDV Registry of Primary Cutaneous Lymphoma
NCT03646422
Fundación Academia Española de Dermatología—
TerminatedPhase II Study of Ibrutinib in Patients With Relapsed or Refractory Marginal Zone Lymphoma
NCT03093831
National Cancer Centre, SingaporePhase 2
UnknownMarginal Zone Lymphoma Cohort in Korea
NCT02732236
Dong-A University Hospital—
WithdrawnOfatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas
NCT01263418
UNC Lineberger Comprehensive Cancer CenterPhase 2